ASO Author Reflections: Innovative HIPEC Organoid Models and Mucolytics: Targeted Therapeutic Use of Bromelain for Appendiceal Cancer

Ann Surg Oncol. 2024 May 14. doi: 10.1245/s10434-024-15428-0. Online ahead of print.

Richard A Erali^{1

2

3

4}, Nadeem Wajih^{1

2}, David L Morris³, Konstantinos I Votanopoulos^{5

6

7

8}

¹ Wake Forest Organoid Research Center (WFORCE), Winston-Salem, NC, USA.
² Wake Forest Institute of Regenerative Medicine (WFIRM), Winston-Salem, NC, USA.
³ Department of Surgery, St. George Hospital, University of New South Wales, Sydney, Australia.
⁴ Division of Surgical Oncology, Department of Surgery, Atrium Health Wake Forest Baptist Health, Wake Forest University, Medical Center Boulevard, Winston Salem, NC, USA.
⁵ Wake Forest Organoid Research Center (WFORCE), Winston-Salem, NC, USA. kvotanop@wakehealth.edu.
⁶ Wake Forest Institute of Regenerative Medicine (WFIRM), Winston-Salem, NC, USA. kvotanop@wakehealth.edu.
⁷ Department of Surgery, St. George Hospital, University of New South Wales, Sydney, Australia. kvotanop@wakehealth.edu.
⁸ Division of Surgical Oncology, Department of Surgery, Atrium Health Wake Forest Baptist Health, Wake Forest University, Medical Center Boulevard, Winston Salem, NC, USA. kvotanop@wakehealth.edu.

No abstract available